One obvious trend has been that dry eye disease is a concurrent problem for virtually all my patients, and we need to address it for optimum comfort and surgical results.
James G. Chelnis, MD
Advertisement
Articles by James G. Chelnis, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Q&A: Peter Kaiser explains the ongoing SOL-1 and SOL-R study of OTX-TKI
2
FDA grants breakthrough therapy designation to Nacuity’s NPI-001 for retinitis pigmentosa
3
Charles Miller, MD, PhD, on DME research and the initiation of the phase 2b/3 BRUNELLO trial
4
AAVantgarde’s AAVB-039 gene therapy to treat Stargardt disease receives orphan drug status from FDA
5
.png "Optometry Times"){kind=logo}
